College of Medicine
February 11, 2026
UAMS Research Shows Online Program Significantly Reduces Benzodiazepine Use in Adults

LITTLE ROCK — A new study involving University of Arkansas for Medical Sciences (UAMS) research scientists offers hope for patients who are seeking to reduce their dependence on benzodiazepines, powerful drugs prescribed to relieve anxiety and insomnia and reduce seizures.
February 9, 2026
UAMS’ Trauma Director Kyle Kalkwarf, M.D., Appointed to Editorial Advisory Board for The Permanente Journal

Kyle Kalkwarf, M.D., medical director of the University of Arkansas for Medical Sciences (UAMS) Trauma Program, recently was appointed as a member of the Editorial Advisory Board for The Permanente Journal, a medical publication that strives to improve health outcomes through the dissemination of innovative research.
February 3, 2026
Digital Health Diabetes Education Improves Health of Rural Communities Across Arkansas

LITTLE ROCK — Delivering family-centered diabetes self-management education and support (DSMES) programs through digital health can significantly improve health outcomes for people with Type 2 diabetes, particularly those living in rural and underserved communities, according to researchers from the University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation.
January 26, 2026
UAMS Hosts American Heart Association Sweethearts for Look at Cardiovascular Research

About 40 Arkansas high school students recently traded their classrooms for cutting-edge laboratories at the University of Arkansas for Medical Sciences (UAMS). The visit provided members of the American Heart Association (AHA) Sweethearts program an exclusive, hands-on look at the types of cardiovascular research performed at UAMS.
January 21, 2026
UAMS Receives $3.5 Million from CDC to Improve Colorectal Cancer Screening

LITTLE ROCK — The Centers for Disease Control and Prevention (CDC) recently awarded more than $3.5 million to the University of Arkansas for Medical Sciences (UAMS) to lead a five-year statewide effort to improve the rate of colorectal cancer screening in the state.
December 19, 2025
UAMS Announces 40 New Full-Tuition Scholarships for Incoming Students in Fall 2026

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today a new initiative for attracting some of the best Arkansas students to UAMS. The program will provide full tuition and fees for 40 exceptional students entering UAMS, including the College of Medicine, with the fall 2026 semester.
December 11, 2025
UAMS Study Reveals Gaps in Obstetric Emergency Preparedness in Arkansas Emergency Departments

LITTLE ROCK — A study from the University of Arkansas for Medical Sciences (UAMS) finds that while obstetric emergencies are common in Arkansas emergency departments (EDs), many hospitals lack key protocols, training and capabilities needed to manage life-threatening maternal complications. UAMS researchers surveyed managers from 51 EDs, representing 61% of all hospital-based EDs statewide, to…
December 9, 2025
Rampy Foundation Relays $51,313 Donation from Bentonville to UAMS Department of Neurology for MS Research

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) Department of Neurology in the College of Medicine received $51,313 for multiple sclerosis research from the Rampy MS Research Foundation during a ceremony today.
December 4, 2025
Vascular Neurologist Jose Miguel Morales, M.D., Joins UAMS

José Miguel Morales, M.D., MSc, a vascular neurologist and neuro-interventional surgeon, has joined the University of Arkansas for Medical Sciences (UAMS) College of Medicine Department of Neurology.
December 2, 2025
UAMS Awarded $10.5 Million as Nationwide Hub to Develop Biomarkers for Human Diseases Including Cancer

UAMS has received a five-year, $10.5 million NIH grant to expand its national proteomics resource, the only one of its kind in the U.S. Led by Alan Tackett, Ph.D., the center provides advanced protein analysis to researchers nationwide, supporting discoveries that lead to new diagnostics, therapies and disease biomarkers.
Next page